Get the Stockscreener App
0.84
5.00%
0.04
Cyclo Therapeutics Inc Stock (CYTH) Forecast
The Cyclo Therapeutics Inc (CYTH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.4993, representing a +316.59% increase from the current price of $0.84. The highest analyst price target is $4.3906, and the lowest is $2.6081.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CYTH Price Target
Average 2.5017
(+197.82% Upside)
Is Cyclo Therapeutics Inc (CYTH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 70.45 | Sell |
| STOCH(9,6) | 83.46 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0376 | Buy |
| ADX(14) | 23.35 | Neutral |
| William %R | -6.4516 | Sell |
| CCI(14) | 160.45 | Buy |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7135
Buy
|
0.7316
Buy
|
| MA20 |
0.6603
Buy
|
0.691
Buy
|
| MA50 |
0.665
Buy
|
0.685
Buy
|
| MA100 |
0.6958
Buy
|
0.76
Buy
|
| MA200 |
0.9794
Sell
|
0.9291
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, CYTH could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 6 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on CYTH, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 70.45 indicates that CYTH is overbought. This suggests that CYTH price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 83.46 indicates that CYTH is oversold. This means that CYTH price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CYTH is oversold. This suggests that CYTH price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.35 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 160.45 indicates that CYTH is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CYTH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cyclo Therapeutics Inc financial reports and earnings history, Cyclo Therapeutics Inc (CYTH) stock could reach $3.0126 by 2030, $11.68 by 2040 and $12.52 by 2050. See the projected annual prices until 2050 of the Cyclo Therapeutics Inc stock below:
- Cyclo Therapeutics Inc (CYTH) is expected to reach an average price of $3.4208 in 2035, with a high prediction of $3.6726 and a low estimate of $3.532. This indicates an $307.24% rise from the last recorded price of $0.84.
- Cyclo Therapeutics Inc (CYTH) stock is projected to chart a bullish course in 2040, with an average price target of $9.7156, representing an $1,057% surge from its current level. The forecast ranges from a conservative $12.01 to a sky-high $11.68.
- Our analysts predict Cyclo Therapeutics Inc (CYTH) to jump 1,701% by 2045, soaring from $14.83 to an average price of $15.13, potentially reaching $14.95. While $14.83 is the low estimate, the potential upside is significant.
- Cyclo Therapeutics Inc (CYTH) stock is expected to climb by 2050, reaching an average of $12.36, a $1,371% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.52 and $12.48, respectively, highlighting the market's uncertainty.
Cyclo Therapeutics Inc Stock (CYTH) Year by Year Forecast
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2025
Cyclo Therapeutics Inc Stock (CYTH) is expected to reach an average price of $2.7154 in 2025, with a high prediction of $5.4149 and a low estimate of $0.0158. This indicates an +223.26% rise from the last recorded price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $3.3461 | $2.6081 | $4.3906 | +298.34% |
| March, 2025 | $3.1666 | $2.6812 | $3.9989 | +276.98% |
| April, 2025 | $3.8424 | $2.2721 | $4.1268 | +357.42% |
| May, 2025 | $1.5029 | $1.4129 | $4.9875 | +78.92% |
| June, 2025 | $0.5235 | $0.2235 | $1.8981 | -37.68% |
| July, 2025 | $0.5492 | $0.2541 | $1.9438 | -34.62% |
| August, 2025 | $0.1798 | $0.0844 | $0.9394 | -78.60% |
| September, 2025 | $0.1996 | $0.0248 | $0.7752 | -76.24% |
| October, 2025 | $0.1739 | $0.0158 | $0.3858 | -79.30% |
| November, 2025 | $0.7633 | $0.2388 | $0.5841 | -9.13% |
| December, 2025 | $0.5876 | $0.6385 | $0.6582 | -30.05% |
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2026
The predicted value for Cyclo Therapeutics Inc (CYTH) in 2026 is set at an average of $0.7831. Estimates vary from a peak of $1.2053 to a trough of $0.361, indicating an -6.77% surge from the present price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.717 | $0.6673 | $0.637 | -14.64% |
| February, 2026 | $0.7065 | $0.6047 | $0.6665 | -15.90% |
| March, 2026 | $0.3759 | $0.361 | $0.3513 | -55.25% |
| April, 2026 | $0.8339 | $0.5207 | $0.6102 | -0.73% |
| May, 2026 | $0.6296 | $0.6099 | $0.4496 | -25.05% |
| June, 2026 | $1.069 | $0.5593 | $1.029 | +27.26% |
| July, 2026 | $0.4633 | $0.7011 | $0.9987 | -44.85% |
| August, 2026 | $0.4227 | $0.7181 | $0.7278 | -49.68% |
| September, 2026 | $0.457 | $0.4024 | $0.3373 | -45.60% |
| October, 2026 | $0.6664 | $0.7418 | $0.9115 | -20.67% |
| November, 2026 | $1.1759 | $0.9013 | $0.9658 | +39.99% |
| December, 2026 | $1.0298 | $1.2517 | $1.2053 | +22.60% |
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cyclo Therapeutics Inc (CYTH) is $0.4036, with a high forecast of $0.7712 and a low forecast of $0.0359. This indicates an -51.95% decrease from the last price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6616 | $0.7795 | $0.7247 | -21.23% |
| February, 2027 | $0.371 | $0.3289 | $0.681 | -55.83% |
| March, 2027 | $0.3132 | $0.0738 | $0.51 | -62.71% |
| April, 2027 | $0.2327 | $0.2772 | $0.3564 | -72.30% |
| May, 2027 | $0.0621 | $0.1721 | $0.2024 | -92.61% |
| June, 2027 | $0.4264 | $0.1118 | $0.2782 | -49.24% |
| July, 2027 | $0.5809 | $0.6012 | $0.5309 | -30.85% |
| August, 2027 | $0.2052 | $0.2104 | $0.5006 | -75.57% |
| September, 2027 | $0.4605 | $0.0733 | $0.5105 | -45.18% |
| October, 2027 | $0.2611 | $0.0359 | $0.5457 | -68.92% |
| November, 2027 | $0.4217 | $0.2462 | $0.7712 | -49.80% |
| December, 2027 | $0.4274 | $0.2468 | $0.652 | -49.12% |
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2028
In 2028, Cyclo Therapeutics Inc (CYTH) is projected to reach an average price of $4.9101, with a high projection of $9.7923 and a low estimate of $0.028. This indicates an +484.54% rise from the last price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.168 | $0.028 | $0.628 | -80.00% |
| February, 2028 | $0.3585 | $0.0317 | $0.3784 | -57.32% |
| March, 2028 | $3.0591 | $0.3637 | $3.1394 | +264.18% |
| April, 2028 | $2.402 | $1.938 | $7.322 | +185.95% |
| May, 2028 | $2.0535 | $0.2165 | $9.7923 | +144.46% |
| June, 2028 | $1.1546 | $0.266 | $7.0737 | +37.45% |
| July, 2028 | $1.6758 | $0.4851 | $1.7858 | +99.50% |
| August, 2028 | $1.0372 | $0.1161 | $2.8661 | +23.48% |
| September, 2028 | $2.9084 | $0.7175 | $5.5875 | +246.23% |
| October, 2028 | $1.7395 | $0.6195 | $3.1086 | +107.08% |
| November, 2028 | $0.411 | $0.189 | $1.8298 | -51.08% |
| December, 2028 | $0.1179 | $0.0618 | $0.8812 | -85.97% |
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2029
The 2029 price forecast for Cyclo Therapeutics Inc Stock (CYTH) is $1.8205 on average, with a high prediction of $3.5164 and a low estimate of $0.1247. This represents an +116.73% increase from the previous price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0765 | $0.237 | $0.5653 | -90.90% |
| February, 2029 | $0.5147 | $0.1247 | $0.7537 | -38.73% |
| March, 2029 | $1.7641 | $1.3344 | $1.675 | +110.02% |
| April, 2029 | $2.683 | $2.266 | $2.2433 | +219.40% |
| May, 2029 | $2.5815 | $2.3524 | $2.4271 | +207.33% |
| June, 2029 | $2.8904 | $2.911 | $2.6904 | +244.09% |
| July, 2029 | $3.2092 | $2.9298 | $2.9342 | +282.05% |
| August, 2029 | $3.1078 | $2.9484 | $2.929 | +269.98% |
| September, 2029 | $3.6366 | $3.1575 | $3.4574 | +332.93% |
| October, 2029 | $3.3852 | $3.4664 | $3.5164 | +303.00% |
| November, 2029 | $3.4541 | $3.4346 | $3.3741 | +311.20% |
| December, 2029 | $3.3829 | $3.3115 | $3.3429 | +302.73% |
Cyclo Therapeutics Inc Stock (CYTH) Price Forecast for 2030
Cyclo Therapeutics Inc Stock (CYTH) is expected to reach an average price of $2.8329 in 2030, with a high forecast of $3.448 and a low forecast of $2.2178. This signifies an +237.25% surge from the last price of $0.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0815 | $2.992 | $3.0126 | +266.84% |
| February, 2030 | $3.374 | $3.1612 | $3.1503 | +301.67% |
| March, 2030 | $3.1092 | $3.1197 | $2.9292 | +270.14% |
| April, 2030 | $3.488 | $3.0086 | $3.448 | +315.24% |
| May, 2030 | $2.8066 | $3.0444 | $3.3874 | +234.11% |
| June, 2030 | $2.7054 | $3.0463 | $3.0257 | +222.07% |
| July, 2030 | $2.664 | $2.6548 | $2.5745 | +217.14% |
| August, 2030 | $2.8128 | $2.9337 | $3.0731 | +234.86% |
| September, 2030 | $3.2618 | $3.0325 | $3.0517 | +288.30% |
| October, 2030 | $3.0399 | $3.3224 | $3.2411 | +261.89% |
| November, 2030 | $2.6112 | $2.7291 | $2.6894 | +210.85% |
| December, 2030 | $1.5179 | $2.2178 | $2.4988 | +80.70% |
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):